Xopenex hfa and Nasacort drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Xopenex hfa (levalbuterol tartrate) and Nasacort (triamcinolone acetonide). Common drug interactions include multiple allergies among females and dysgeusia among males.

The phase IV clinical study analyzes what interactions people have when they take Xopenex hfa and Nasacort. It is created by eHealthMe based on reports of 83 people who take the same drugs from the FDA, and is updated regularly.

What is Xopenex hfa?

Xopenex hfa has active ingredients of levalbuterol tartrate. It is often used in asthma. eHealthMe is studying from 2,529 Xopenex hfa users. Check the latest studies of Xopenex hfa.

What is Nasacort?

Nasacort has active ingredients of triamcinolone acetonide. It is often used in allergies. eHealthMe is studying from 13,298 Nasacort users. Check the latest studies of Nasacort.

On Aug, 03, 2026

83 people who take Xopenex hfa and Nasacort together, and have interactions are studied.

Xopenex hfa and Nasacort drug interactions.

What are the common drug interactions of Xopenex Hfa and Nasacort, by gender? *:

female:

Multiple allergies (allergy to multiple agents)
Osteoarthritis (a joint disease caused by cartilage loss in a joint)
Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
Sinusitis (inflammation of sinus)
Skin papilloma (a general medical term for a tumour of the skin or mucous membrane with finger-like projections)
Tremor (trembling or shaking movements in one or more parts of your body)
Urinary tract infection
Weight decreased
Injection site pain

male:

Dysgeusia (disorder of the sense of taste)
Dyspnoea (difficult or laboured respiration)
Left ventricular hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart)
Leukocytosis (increased white blood cells)
Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
Pneumonia
Hypersensitivity
Anaphylactic reaction (serious allergic reaction)
Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection)
Fatigue (feeling of tiredness)

What are the common drug interactions of Xopenex Hfa and Nasacort, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Depression
Overdose
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Self-injurious ideation
Suicide attempt
Blood glucose increased
Dyspnoea (difficult or laboured respiration)
Malaise (a feeling of general discomfort or uneasiness)
Mood swings (an extreme or rapid change in mood)
Postural orthostatic tachycardia syndrome (abnormal increase in heart rate on becoming upright)

30-39:

Abdominal pain
Anaphylactic reaction (serious allergic reaction)
Gallbladder disorder
Injection site pain
Laryngospasm (an uncontrolled/involuntary muscular contraction of larynx)

40-49:

Abdominal pain
Cough
Hypersensitivity
Dyspnoea (difficult or laboured respiration)
Drug hypersensitivity

50-59:

Breath holding
Disability
Emotional distress
Fatigue (feeling of tiredness)
Gastrointestinal pain
Headache (pain in head)
Hypersensitivity
Nausea (feeling of having an urge to vomit)
Polyarthritis (arthritis which involves 5 or more joints simultaneously)
Spinal fusion surgery

60+:

Nephrolithiasis (calculi in the kidneys)
Pneumonia
Herpes zoster
Migraine (headache)
Peripheral swelling
Sepsis (a severe blood infection that can lead to organ failure and death)
Uveitis (inflammation of the uvea)
Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
Hypersensitivity
Lower respiratory tract infection

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 37 people, 44.58%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 24 people, 28.92%
Immunodeficiency Common Variable: 11 people, 13.25%
Pain: 8 people, 9.64%
Primary Immunodeficiency Syndrome: 7 people, 8.43%
Hypersensitivity: 7 people, 8.43%
Stress And Anxiety: 6 people, 7.23%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 6.02%

* Approximation only. Some reports may have incomplete information.

Do you take Xopenex hfa and Nasacort?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously